Related references
Note: Only part of the references are listed.Correlating Immune Cell Infiltration Patterns with Recurrent Somatic Mutations in Advanced Clear Cell Renal Cell Carcinoma br
Nicholas H. Chakiryan et al.
EUROPEAN UROLOGY FOCUS (2022)
BAP1-Mutated Clear Cell Renal Cell Carcinoma A Clinicopathologic Characterization of 14 Molecularly Confirmed Tumors
Alexander J. Gallan et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
Kevin Bi et al.
CANCER CELL (2021)
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition
Kevin Litchfield et al.
CELL (2021)
Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity
Gabriel K. Griffin et al.
NATURE (2021)
Prognostic and Predictive Value of PBRM1 in Clear Cell Renal Cell Carcinoma
Lucia Carril-Ajuria et al.
CANCERS (2020)
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
David A. Braun et al.
NATURE MEDICINE (2020)
Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer
Alessandra Raimondi et al.
FRONTIERS IN ONCOLOGY (2020)
A pan-cancer analysis of PBAF complex mutations and their association with immunotherapy response
A. Ari Hakimi et al.
NATURE COMMUNICATIONS (2020)
Currently favored sampling practices for tumor sequencing can produce optimal results in the clinical setting
Lorinc S. Pongor et al.
SCIENTIFIC REPORTS (2020)
Epidemiology of Renal Cell Carcinoma
Sandeep Anand Padala et al.
WORLD JOURNAL OF ONCOLOGY (2020)
Comprehensive Analysis of Driver Genes in Personal Genomes of Clear Cell Renal Cell Carcinoma
Jin Li et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2019)
Genomic Alterations of Renal Cell Carcinoma and Clinical Implications in the Chinese Population
Shudong Zhang et al.
MEDICAL SCIENCE MONITOR (2019)
Clinical Validation of PBRM1 Alterations as a Marker of Immune Checkpoint Inhibitor Response in Renal Cell Carcinoma
David A. Braun et al.
JAMA ONCOLOGY (2019)
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J. Havel et al.
NATURE REVIEWS CANCER (2019)
Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies
Peter Makhov et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
David F. McDermott et al.
NATURE MEDICINE (2018)
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma (vol 23, pg 313, 2018)
Christopher J. Ricketts et al.
CELL REPORTS (2018)
Factors that drive the increasing use of FFPE tissue in basic and translational cancer research
E. F. Gaffney et al.
BIOTECHNIC & HISTOCHEMISTRY (2018)
Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study
Martin H. Voss et al.
LANCET ONCOLOGY (2018)
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
N. C. Turner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Heterogeneity in renal cell carcinoma
Alp Tuna Beksac et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer
Guilhem Bousquet et al.
ONCOTARGET (2017)
Prognostic value of KRAS mutation in advanced non-small-cell lung cancer treated with immune checkpoint inhibitors: A meta-analysis and review
Jung Han Kim et al.
ONCOTARGET (2017)
Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell Carcinoma
Andre P. Fay et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2016)
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy
A. Ravaud et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Comparative genomic analysis of primary tumors and metastases in breast cancer
Francois Bertucci et al.
ONCOTARGET (2016)
Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus
Sun Min Lim et al.
ONCOTARGET (2016)
Correlation Between Molecular Subclassifications of Clear Cell Renal Cell Carcinoma and Targeted Therapy Response
Thai H. Ho et al.
EUROPEAN UROLOGY FOCUS (2016)
Assessing the quality of published genetic association studies in meta-analyses: the quality of genetic studies (Q-Genie) tool
Zahra N. Sohani et al.
BMC GENETICS (2015)
Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data The PRISMA-IPD Statement
Lesley A. Stewart et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Tracking sub-clonal TP53 mutated tumor cells in human metastatic renal cell carcinoma
Guilhem Bousquet et al.
ONCOTARGET (2015)
Stem cells increase in numbers in peri-necrotic areas in human renal cancer
Mariana Varna et al.
CLINICAL CANCER RESEARCH (2015)
UBE3C Promotes Growth and Metastasis of Renal Cell Carcinoma via Activating Wnt/β- Catenin Pathway
Ji Ling Wen et al.
PLOS ONE (2015)
The Chromatin Remodeling Gene ARID1A Is a New Prognostic Marker in Clear Cell Renal Cell Carcinoma
Zsuzsanna Lichner et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
Gregg L. Semenza
JOURNAL OF CLINICAL INVESTIGATION (2013)
Integrated molecular analysis of clear-cell renal cell carcinoma
Yusuke Sato et al.
NATURE GENETICS (2013)
ARID1A Mutations in Cancer: Another Epigenetic Tumor Suppressor?
Jennifer N. Wu et al.
CANCER DISCOVERY (2013)
BAP1 loss defines a new class of renal cell carcinoma
Samuel Pena-LlopiS et al.
NATURE GENETICS (2012)
Targeted-Therapy in Advanced Renal Cell Carcinoma
M. T. Pirrotta et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Epigenetic modifications as therapeutic targets
Theresa K. Kelly et al.
NATURE BIOTECHNOLOGY (2010)
Prognostic factors in renal cell carcinoma
Alessandro Volpe et al.
WORLD JOURNAL OF UROLOGY (2010)
The SWI/SNF complex and cancer
D. Reisman et al.
ONCOGENE (2009)
Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors
Michael L. Nickerson et al.
CLINICAL CANCER RESEARCH (2008)
Identification and characterization of a novel human histone H3 lysine 36-specific methyltransferase
XJ Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Effect of fixatives and tissue processing on the content and integrity of nucleic acids
M Srinivasan et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Share Paper
